Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 1057Stomach Neoplasms 802Carcinoma, Hepatocellular 785Pancreatic Neoplasms 577Rectal Neoplasms 449Colonic Neoplasms 405Esophageal Neoplasms 363Liver Neoplasms 225Esophageal Squamous Cell Carcinoma 144Neoplasms 134Cholangiocarcinoma 129Neoplasm Metastasis 117Breast Neoplasms 117Gastrointestinal Neoplasms 105Lung Neoplasms 76Biliary Tract Neoplasms 73Recurrence 61Prostatic Neoplasms 52Ovarian Neoplasms 49Barrett Esophagus 47Carcinoma, Non-Small-Cell Lung 44Anastomotic Leak 43Bile Duct Neoplasms 42Gastrointestinal Stromal Tumors 40Gallbladder Neoplasms 40Head and Neck Neoplasms 38Digestive System Neoplasms 35Anus Neoplasms 34Colonic Polyps 33Adenocarcinoma Of Esophagus 32

Interventions

camrelizumab 1Radiotherapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Esophageal Malignant Neoplasm, Local Recurrence × Gastrointestinal × Clear all
NCT04404491 2020-05-27

Clinical Control Study of Immunotherapy and Concurrent Chemoradiotherapy in Patients With Esophageal Cancer Recurrence

The First Affiliated Hospital of Henan University of Science and Technology

Phase 3 Unknown
240 enrolled
GastrointestinalOther neoplasm

Esophageal Malignant Neoplasm, Local Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡